ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $134,335 | -87.1% | 40,100 | -81.5% | 0.00% | -85.0% |
| Q4 2022 | $1,040,331 | -20.7% | 216,285 | -6.1% | 0.02% | -23.1% |
| Q3 2022 | $1,312,000 | +26.3% | 230,364 | +57.5% | 0.03% | +36.8% |
| Q2 2022 | $1,039,000 | -1.6% | 146,224 | +0.1% | 0.02% | +18.8% |
| Q1 2022 | $1,056,000 | +21.7% | 146,128 | +50.5% | 0.02% | +45.5% |
| Q4 2021 | $868,000 | -28.7% | 97,077 | +179.7% | 0.01% | -31.2% |
| Q3 2021 | $1,217,000 | – | 34,704 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |